The Long-Acting Echinocandin, Rezafungin, Prevents Pneumocystis Pneumonia and Eliminates Pneumocystis from the Lungs in Prophylaxis and Murine Treatment Models.
PCP
Pneumocystis jirovecii pneumonia (PJP) Pneumocystis
echinocandin
obligate sexual reproduction
rezafungin
Journal
Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827
Informations de publication
Date de publication:
11 Sep 2021
11 Sep 2021
Historique:
received:
04
08
2021
revised:
03
09
2021
accepted:
08
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
Rezafungin is a novel echinocandin in Phase 3 development for prevention of invasive fungal disease caused by
Identifiants
pubmed: 34575785
pii: jof7090747
doi: 10.3390/jof7090747
pmc: PMC8468546
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : BLRD VA
ID : I01 BX004441
Pays : United States
Organisme : BLRD VA
ID : IK6 BX005232
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146266
Pays : United States
Organisme : Cidara Therapeutics
ID : none
Références
J Antimicrob Chemother. 2016 Sep;71(9):2397-404
pubmed: 27550992
Expert Rev Anti Infect Ther. 2019 Oct;17(10):787-801
pubmed: 31550942
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27919901
Antimicrob Agents Chemother. 2020 Mar 24;64(4):
pubmed: 32015043
Cleve Clin J Med. 2019 Jul;86(7):449-453
pubmed: 31291178
Respiration. 2018;96(1):52-65
pubmed: 29635251
Future Microbiol. 2021 Jan;16(1):27-36
pubmed: 33438477
Rheumatol Adv Pract. 2020 Jul 06;4(2):rkaa029
pubmed: 33134810
J Fungi (Basel). 2020 Sep 28;6(4):
pubmed: 32998224
J Antimicrob Chemother. 2018 Jan 1;73(suppl_1):i60-i72
pubmed: 29304213
Sci Rep. 2021 Feb 3;11(1):2877
pubmed: 33536529
PLoS Pathog. 2018 Dec 6;14(12):e1007409
pubmed: 30521646
Exp Ther Med. 2018 Feb;15(2):1594-1601
pubmed: 29399131
Expert Rev Anti Infect Ther. 2017 Sep;15(9):873-892
pubmed: 28782390
AIDS. 2019 Jul 1;33(8):1345-1351
pubmed: 30932964
Bone Marrow Transplant. 2019 Jul;54(7):1082-1088
pubmed: 30413810
Parasitol Res. 2015 Oct;114(10):3577-85
pubmed: 26281787
J Antimicrob Chemother. 2019 Dec 1;74(12):3505-3510
pubmed: 31539426
Antimicrob Agents Chemother. 2010 Jun;54(6):2497-506
pubmed: 20385855
Clin Infect Dis. 2009 May 15;48(10):1441-58
pubmed: 19361301
Pharmacol Res. 2018 Aug;134:61-67
pubmed: 29890253
Clin Transplant. 2019 Sep;33(9):e13587
pubmed: 31077616
J Immunol Res. 2019 Dec 1;2019:8105075
pubmed: 31886310
Antimicrob Agents Chemother. 2018 Jan 25;62(2):
pubmed: 29203480
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29463544
Transplant Proc. 2013 Oct;45(8):3057-60
pubmed: 24157035
HIV Med. 2021 Apr;22(4):307-313
pubmed: 33277811
J Antimicrob Chemother. 2016 Sep;71(9):2379-85
pubmed: 27550990
Am J Transplant. 2015 Jan;15(1):190-9
pubmed: 25496195
PLoS One. 2010 Jan 29;5(1):e8524
pubmed: 20126455
J Eukaryot Microbiol. 2001;Suppl:178S-179S
pubmed: 11906052
J Glob Antimicrob Resist. 2018 Sep;14:58-64
pubmed: 29486356
Clin Infect Dis. 2020 Sep 21;:
pubmed: 32955088
Transpl Infect Dis. 2012 Oct;14(5):519-25
pubmed: 22571389
Mycopathologia. 2020 Oct;185(5):783-800
pubmed: 31782069
J Eukaryot Microbiol. 2006 Jan-Feb;53(1):2-11
pubmed: 16441572
J Antimicrob Chemother. 2018 Nov 1;73(11):3063-3067
pubmed: 30032217
Antimicrob Agents Chemother. 2021 Feb 17;65(3):
pubmed: 33318018
Infect Immun. 2002 Nov;70(11):6107-13
pubmed: 12379687
Mayo Clin Proc. 2021 Feb;96(2):400-407
pubmed: 33549258
Annu Rev Microbiol. 2010;64:431-52
pubmed: 20528694